Top reads from the CHEST journal portfolio
Editorial board memebers share their picks of top journal articles in recent months.
Editorial board memebers share their picks of top journal articles in recent months.
The author describes the science behind a study of ponsegromab to treat cancer cachexia. Ponsegromab suppresses a pathway in neurons located in specific regions of…
Illustrated Glossary from The New England Journal of Medicine
Click on the article title to read more.
Airway diseases are a heterogeneous group of disorders that impact airflow. Recent advances in the field are providing important insights into the management of these…
Rationale: Relatives of patients with familial pulmonary fibrosis (FPF) are at increased risk to develop FPF. Interstitial lung abnormalities (ILAs) are a radiologic biomarker of…
Rationale: Some with interstitial lung abnormalities (ILA) are suspected to have interstitial lung disease (ILD), a subgroup with adverse outcomes. Rates of development and progression…
“.” Annals of the American Thoracic Society, 21(12), pp. 1770–1773 Correspondence and requests for reprints should be addressed to Sujith V. Cherian, M.D., University of…
Idiopathic pulmonary fibrosis (IPF) is an aggressive and, thus far, incurable disease characterized by aberrant fibroblast-mediated extracellular matrix deposition. Our understanding of the disease…
Idiopathic pulmonary fibrosis (IPF) and other forms of fibrotic interstitial lung diseases (ILDs) often follow a relentlessly progressive course, with median survival frequently cited as…
Audio Interview from the New England Journal of Medicine — Interview with Lauren Schiff on the need for improved training and increased comfort in treating…